Hans-Joachim Schmoll, MD, PhD | Authors

CHARTA Shows Survival Benefit of Four-Drug Regimen for Advanced CRC

January 21, 2017

This video examines results of the CHARTA trial, which tested first-line FOLFOX plus bevacizumab with or without irinotecan in patients with advanced colorectal cancer.